Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Health Economics Review|January 17, 2021
Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysisJörg Mahlich, Arne Bartol, Srirangan DhebanJournal of Cancer Research and Clinical Oncology|October 1, 2022
Ten years of AMNOG from an oncological perspective: new horizons and continuing expansionArne Bartol, Katrin Dressler, Peter Kaskel, et al.Health Economics, Policy, and Law|August 14, 2023
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefitKatrin Kleining, Jan Laufenberg, Philip Thrun, et al.Nature Protocols|August 1, 2009
Spheroid-based human endothelial cell microvessel formation in vivoAnna M Laib, Arne Bartol, Abdullah Alajati, et al.Health Economics Review|April 12, 2024
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical modelIris An der Heiden, Guido Schiffhorst, Laura Müller, et al.Cytotherapy|March 16, 2013
Recruitment of human cord blood-derived endothelial colony-forming cells to sites of tumor angiogenesisKaren Bieback, Maria Vinci, Susanne Elvers-Hornung, et al.Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signalingJoycelyn Wüstehube, Arne Bartol, Sven S Liebler, et al.Circulation Research|July 10, 2010
Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesisRené Brütsch, Sven S Liebler, Joycelyn Wüstehube, et al.Nature Communications|July 19, 2017
Pericyte-expressed Tie2 controls angiogenesis and vessel maturationMartin Teichert, Laura Milde, Annegret Holm, et al.Nature Methods|April 9, 2008
Spheroid-based engineering of a human vasculature in miceAbdullah Alajati, Anna M Laib, Holger Weber, et al.Pageof 2